U-BLRX

Q:BLRX - BIOLINE RX LTD SPON ADS EACH REPR 15 ORD SHS - http://www.biolinerx.com

08:42:22 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BLRX - Q	0.1	0.5607	·	0.64	0.3	0.613							2.53 0.61	Apr 24	Apr 17	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - All 0 today

More trades...

Time ET	Ex	Price	Change	Volume

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2024-04-17 07:00	U:BLRX	News Release200	BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA(TM) (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
2024-04-10 07:00	U:BLRX	News Release200	BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement
2024-04-01 09:00	U:BLRX	News Release200	BioLineRx Announces $6 Million Registered Direct Offering

Date ET

Symbol

Type

Headline

2024-04-17 07:00

U:BLRX

News Release

BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA(TM) (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting

2024-04-10 07:00

U:BLRX

News Release

BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement

2024-04-01 09:00

U:BLRX

News Release

BioLineRx Announces $6 Million Registered Direct Offering